These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 24342385

  • 21. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
    Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL, Risperidone Disruptive Behavior Study Group.
    Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
    [Abstract] [Full Text] [Related]

  • 22. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
    Blader JC, Schooler NR, Jensen PS, Pliszka SR, Kafantaris V.
    Am J Psychiatry; 2009 Dec; 166(12):1392-401. PubMed ID: 19884222
    [Abstract] [Full Text] [Related]

  • 23. Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials.
    LeBlanc JC, Binder CE, Armenteros JL, Aman MG, Wang JS, Hew H, Kusumakar V.
    Int Clin Psychopharmacol; 2005 Sep; 20(5):275-83. PubMed ID: 16096518
    [Abstract] [Full Text] [Related]

  • 24. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH, Nagy P, Childress AC, Frick G, Yan B, Pliszka S.
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [Abstract] [Full Text] [Related]

  • 25. A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.
    Arnold LE, Ober N, Aman MG, Handen B, Smith T, Pan X, Hyman SL, Hollway J, Lecavalier L, Page K, Rice R.
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):322-330. PubMed ID: 29694241
    [Abstract] [Full Text] [Related]

  • 26. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
    Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.
    Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
    [Abstract] [Full Text] [Related]

  • 27. Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.
    Penzner JB, Dudas M, Saito E, Olshanskiy V, Parikh UH, Kapoor S, Chekuri R, Gadaleta D, Avedon J, Sheridan EM, Randell J, Malhotra AK, Kane JM, Correll CU.
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):563-73. PubMed ID: 19877981
    [Abstract] [Full Text] [Related]

  • 28. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.
    Findling RL, Bukstein OG, Melmed RD, López FA, Sallee FR, Arnold LE, Pratt RD.
    J Clin Psychiatry; 2008 Jan; 69(1):149-59. PubMed ID: 18312050
    [Abstract] [Full Text] [Related]

  • 29. Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children.
    Chronis-Tuscano A, French W, Strickland J, Sasser T, Gonzalez ENS, Whitlock KB, Stein MA.
    J Clin Psychiatry; 2020 Sep 08; 81(5):. PubMed ID: 32926603
    [Abstract] [Full Text] [Related]

  • 30. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
    Handen BL, Aman MG, Arnold LE, Hyman SL, Tumuluru RV, Lecavalier L, Corbett-Dick P, Pan X, Hollway JA, Buchan-Page KA, Silverman LB, Brown NV, Rice RR, Hellings J, Mruzek DW, McAuliffe-Bellin S, Hurt EA, Ryan MM, Levato L, Smith T.
    J Am Acad Child Adolesc Psychiatry; 2015 Nov 08; 54(11):905-15. PubMed ID: 26506581
    [Abstract] [Full Text] [Related]

  • 31. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
    Sinzig J, Döpfner M, Lehmkuhl G, German Methylphenidate Study Group, Uebel H, Schmeck K, Poustka F, Gerber WD, Günter M, Knölker U, Gehrke M, Hässler F, Resch F, Brünger M, Ose C, Fischer R.
    J Child Adolesc Psychopharmacol; 2007 Aug 08; 17(4):421-32. PubMed ID: 17822338
    [Abstract] [Full Text] [Related]

  • 32. Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct/oppositional-defiant disorder, and aggression: a prospective, open-label study.
    Kronenberger WG, Giauque AL, Lafata DE, Bohnstedt BN, Maxey LE, Dunn DW.
    J Child Adolesc Psychopharmacol; 2007 Jun 08; 17(3):334-47. PubMed ID: 17630867
    [Abstract] [Full Text] [Related]

  • 33. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.
    Pediatrics; 2004 Nov 08; 114(5):e634-41. PubMed ID: 15492353
    [Abstract] [Full Text] [Related]

  • 34. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD.
    Blader JC, Pliszka SR, Jensen PS, Schooler NR, Kafantaris V.
    Pediatrics; 2010 Oct 08; 126(4):e796-806. PubMed ID: 20837589
    [Abstract] [Full Text] [Related]

  • 35. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T, Hirsch L, Gardner D, Gorman DA.
    Can J Psychiatry; 2015 Feb 08; 60(2):42-51. PubMed ID: 25886655
    [Abstract] [Full Text] [Related]

  • 36. Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed - Results from a randomized, double-blind, placebo-controlled clinical trial.
    Jahangard L, Akbarian S, Haghighi M, Ahmadpanah M, Keshavarzi A, Bajoghli H, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S.
    Psychiatry Res; 2017 May 08; 251():182-191. PubMed ID: 28213188
    [Abstract] [Full Text] [Related]

  • 37. Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.
    Gorman DA, Gardner DM, Murphy AL, Feldman M, Bélanger SA, Steele MM, Boylan K, Cochrane-Brink K, Goldade R, Soper PR, Ustina J, Pringsheim T.
    Can J Psychiatry; 2015 Feb 08; 60(2):62-76. PubMed ID: 25886657
    [Abstract] [Full Text] [Related]

  • 38. Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study.
    Smith T, Aman MG, Arnold LE, Silverman LB, Lecavalier L, Hollway J, Tumuluru R, Hyman SL, Buchan-Page KA, Hellings J, Rice RR, Brown NV, Pan X, Handen BL.
    J Am Acad Child Adolesc Psychiatry; 2016 Oct 08; 55(10):868-876.e2. PubMed ID: 27663942
    [Abstract] [Full Text] [Related]

  • 39. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.
    Findling RL, Aman MG, Eerdekens M, Derivan A, Lyons B, Risperidone Disruptive Behavior Study Group.
    Am J Psychiatry; 2004 Apr 08; 161(4):677-84. PubMed ID: 15056514
    [Abstract] [Full Text] [Related]

  • 40. TOSCA: no longer just an opera.
    Jensen PS.
    J Am Acad Child Adolesc Psychiatry; 2014 Sep 08; 53(9):938-41. PubMed ID: 25151415
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.